EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,778 | -99.9% | 274,995 | 0.0% | 0.13% | +33.7% |
| Q3 2022 | $2,727,000 | +1.3% | 274,995 | 0.0% | 0.10% | -4.9% |
| Q2 2022 | $2,692,000 | +0.3% | 274,995 | 0.0% | 0.10% | +8.4% |
| Q1 2022 | $2,685,000 | +121.5% | 274,995 | +120.0% | 0.10% | +216.7% |
| Q4 2021 | $1,212,000 | -0.4% | 124,998 | 0.0% | 0.03% | -33.3% |
| Q3 2021 | $1,217,000 | +0.2% | 124,998 | 0.0% | 0.04% | +28.6% |
| Q2 2021 | $1,214,000 | – | 124,998 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |